Cargando…

Implications of Seizure-Cluster Treatment on Healthcare Utilization: Use of Approved Rescue Medications

PURPOSE: People with epilepsy may experience seizure clusters despite a stable regimen of antiseizure medications. Such clusters have the potential to last ≥24 hours, typically occur in the community setting, and may progress to medical emergencies, such as status epilepticus, if untreated. Thus, lo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rabinowicz, Adrian L, Faught, Edward, Cook, David F, Carrazana, Enrique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619205/ https://www.ncbi.nlm.nih.gov/pubmed/36325434 http://dx.doi.org/10.2147/NDT.S376104

Ejemplares similares

Overcoming the challenges of developing an intranasal diazepam rescue therapy for the treatment of seizure clusters
por: Cloyd, James, et al.
Publicado: (2021)

Treatment of Seizure Clusters in Epilepsy: A Narrative Review on Rescue Therapies
por: Becker, Danielle A., et al.
Publicado: (2023)

Use of intranasal rescue therapy for seizure clusters in students with epilepsy: Nurses’ knowledge, perceptions, and practice
por: Santilli, Nancy, et al.
Publicado: (2023)

Significant improvements in SEIzure interVAL (time between seizure clusters) across time in patients treated with diazepam nasal spray as intermittent rescue therapy for seizure clusters
por: Misra, Sunita N., et al.
Publicado: (2022)

The nose has it: Opportunities and challenges for intranasal drug administration for neurologic conditions including seizure clusters
por: Chung, Steve, et al.
Publicado: (2022)

Future opportunities for research in rescue treatments
por: Wheless, James W., et al.
Publicado: (2022)

Improvement of Intranasal Drug Delivery with Intravail(®) Alkylsaccharide Excipient as a Mucosal Absorption Enhancer Aiding in the Treatment of Conditions of the Central Nervous System
por: Rabinowicz, Adrian L., et al.
Publicado: (2021)

Use of second doses of Valtoco® (diazepam nasal spray) across 24 hours after the initial dose for out‐of‐hospital seizure clusters: Results from a phase 3, open‐label, repeat‐dose safety study
por: Sperling, Michael R., et al.
Publicado: (2022)

Lack of clinically relevant differences in safety and pharmacokinetics after second‐dose administration of intranasal diazepam within 4 h for acute treatment of seizure clusters: A population analysis
por: Cascino, Gregory D., et al.
Publicado: (2022)

Clarification of Dalfampridine Labeled Indications
por: Rabinowicz, Adrian L., et al.
Publicado: (2012)

Optimizing Absorption for Intranasal Delivery of Drugs Targeting the Central Nervous System Using Alkylsaccharide Permeation Enhancers
por: Madden, Stuart, et al.
Publicado: (2023)

The Cost of the Second Seizure: Rethinking the Treatment Decision
por: Faught, Edward
Publicado: (2019)

Pharmacokinetics and safety of VALTOCO (NRL‐1; diazepam nasal spray) in patients with epilepsy during seizure (ictal/peri‐ictal) and nonseizure (interictal) conditions: A phase 1, open‐label study
por: Hogan, Robert Edward, et al.
Publicado: (2020)

Rescue therapies for seizure clusters: Pharmacology and target of treatments
por: Gidal, Barry, et al.
Publicado: (2022)

Final results from a Phase 3, long‐term, open‐label, repeat‐dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy
por: Wheless, James W., et al.
Publicado: (2021)

Acute seizure therapies in people with epilepsy: Fact or fiction? A U.S. Perspective
por: Tatum, William O., et al.
Publicado: (2023)

Consistent safety and tolerability of Valtoco(®) (diazepam nasal spray) in relationship to usage frequency in patients with seizure clusters: Interim results from a phase 3, long‐term, open‐label, repeat‐dose safety study
por: Miller, Ian, et al.
Publicado: (2021)

Evaluation of Pharmacokinetics and Dose Proportionality of Diazepam After Intranasal Administration of NRL‐1 to Healthy Volunteers
por: Tanimoto, Sarina, et al.
Publicado: (2020)

Safety of Diazepam Nasal Spray in Pediatric Patients With Developmental Epileptic Encephalopathies: Results From a Long-term Phase 3 Safety Study
por: Tarquinio, Daniel, et al.
Publicado: (2023)

Genetic rescue of absence seizures
por: McCafferty, Cian, et al.
Publicado: (2018)

Empowering With Rescue Therapy: A Rescue for More than Just Seizures
por: Becker, Danielle A.
Publicado: (2022)

New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: I. Role of GABA as a Modulator of Seizure Activity and Recently Approved Medications Acting on the GABA System
por: Perucca, Emilio, et al.
Publicado: (2023)

Out-of-hospital rescue medication in dogs with emergency seizure disorders: an owner perspective
por: Kähn, Charlotte, et al.
Publicado: (2023)

Erratum to Empowering with Rescue Therapy: A Rescue for More Than Just Seizures
Publicado: (2022)

Understanding the burden of focal epilepsy as a function of seizure frequency in the United States, Europe, and Brazil
por: Gupta, Shaloo, et al.
Publicado: (2017)

Seizure clusters
por: Mesraoua, Boulenouar, et al.
Publicado: (2021)

Measure for Measure: Measuring the Usefulness of Measuring Antiseizure Medication Levels
por: Faught, Edward
Publicado: (2020)

Circadian and multiday seizure periodicities, and seizure clusters in canine epilepsy
por: Gregg, Nicholas M, et al.
Publicado: (2020)

Are we failing to provide adequate rescue medication to children at risk of prolonged convulsive seizures in schools?
por: Cross, J Helen, et al.
Publicado: (2013)

Seizure-induced reduction in PIP(3) levels contributes to seizure-activity and is rescued by valproic acid()
por: Chang, Pishan, et al.
Publicado: (2014)

Topiramate in the treatment of partial and generalized epilepsy
por: Faught, Edward
Publicado: (2007)

Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long‐term, open‐label safety study
por: Segal, Eric B., et al.
Publicado: (2021)

Seizure Clusters, Seizure Severity Markers, and SUDEP Risk
por: Ochoa-Urrea, Manuela, et al.
Publicado: (2021)

Cannabidiol Rescues Acute Hepatic Toxicity and Seizure Induced by Cocaine
por: Vilela, Luciano Rezende, et al.
Publicado: (2015)

Seizure Clusters: Morbidity and Mortality
por: Bauman, Kristie, et al.
Publicado: (2021)

The Approved Societies and Their Medical Referees
Publicado: (1913)

Utilization of Artificial Intelligence in Disease Prevention: Diagnosis, Treatment, and Implications for the Healthcare Workforce
por: Wani, Shahid Ud Din, et al.
Publicado: (2022)

Efficacy of a pre-specified timeline-based treatment protocol in children with acute repetitive seizures or seizure clusters
por: Sharawat, Indar Kumar, et al.
Publicado: (2023)

Impact of SARS on healthcare utilization by disease categories: Implications for delivery of healthcare services
por: Lu, Tsung-Hsueh, et al.
Publicado: (2007)

Disease-modifying treatments for multiple sclerosis – a review of approved medications
por: Torkildsen, Ø, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_aa4jlhu3pc5ikl3u2me5rrp0fh